Lymphoma, Mantle-Cell

"Lymphoma, Mantle-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).

Descriptor ID	D020522
MeSH Number(s)	C04.557.386.480.525 C15.604.515.569.480.525 C20.683.515.761.480.525
Concept/Terms	Lymphoma, Mantle-Cell Lymphoma, Mantle-Cell Lymphoma, Mantle Cell Lymphomas, Mantle-Cell Mantle-Cell Lymphomas Lymphocytic Lymphoma, Diffuse, Poorly Differentiated Lymphocytic Lymphoma, Diffuse, Poorly-Differentiated Mantle-Zone Lymphoma Lymphoma, Mantle-Zone Lymphomas, Mantle-Zone Mantle Zone Lymphoma Mantle-Zone Lymphomas Lymphoma, Lymphocytic, Diffuse, Intermediate Differentiated Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated Lymphoma, Small-Cell, Centrocytic Mantle-Cell Lymphoma Mantle Cell Lymphoma Diffuse Lymphocytic Lymphoma, Poorly-Differentiated Diffuse Lymphocytic Lymphoma, Poorly Differentiated Lymphoma, Centrocytic Small-Cell Centrocytic Small-Cell Lymphoma Centrocytic Small-Cell Lymphomas Lymphoma, Centrocytic Small Cell Lymphomas, Centrocytic Small-Cell Small-Cell Lymphoma, Centrocytic Small-Cell Lymphomas, Centrocytic Lymphoma, Lymphocytic, Intermediate Lymphoma, Lymphocytic, Intermediate

Below are MeSH descriptors whose meaning is more general than "Lymphoma, Mantle-Cell".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, Mantle-Cell [C04.557.386.480.525]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, Mantle-Cell [C15.604.515.569.480.525]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, Mantle-Cell [C20.683.515.761.480.525]

Below are MeSH descriptors whose meaning is related to "Lymphoma, Mantle-Cell".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Mantle-Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, Mantle-Cell" by people in this website by year, and whether "Lymphoma, Mantle-Cell" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2001	1	0	1
2003	1	0	1
2005	2	0	2
2006	0	1	1
2009	1	0	1
2018	1	0	1
2019	1	0	1

Below are the most recent publications written about "Lymphoma, Mantle-Cell" by people in Profiles.

Greenwell IB, Cohen JB. When to use stem cell transplant in mantle cell lymphoma. Expert Rev Hematol. 2019 04; 12(4):207-210.

View in: PubMed
Greenwell IB, Staton AD, Lee MJ, Switchenko JM, Saxe DF, Maly JJ, Blum KA, Grover NS, Mathews SP, Gordon MJ, Danilov AV, Epperla N, Fenske TS, Hamadani M, Park SI, Flowers CR, Cohen JB. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Cancer. 2018 06 01; 124(11):2306-2315.

View in: PubMed
Gustafsson K, Sander B, Bielawski J, Hannun YA, Flygare J. Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism. Mol Cancer Res. 2009 Jul; 7(7):1086-98.

View in: PubMed
Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. 2006 Dec; 135(5):642-50.

View in: PubMed
Marzec M, Kasprzycka M, Lai R, Gladden AB, Wlodarski P, Tomczak E, Nowell P, Deprimo SE, Sadis S, Eck S, Schuster SJ, Diehl JA, Wasik MA. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood. 2006 Sep 01; 108(5):1744-50.

View in: PubMed
Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene. 2006 Feb 16; 25(7):998-1007.

View in: PubMed
Caraway NP, Gu J, Lin P, Romaguera JE, Glassman A, Katz R. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens. Cancer. 2005 Apr 25; 105(2):110-8.

View in: PubMed
Kasamon YL, Jones RJ, Diehl LF, Nayer H, Borowitz MJ, Garrett-Mayer E, Ambinder RF, Abrams RA, Zhang Z, Flinn IW. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant. 2005 Jan; 11(1):39-46.

View in: PubMed
Khoury JD, Sen F, Abruzzo LV, Hayes K, Glassman A, Medeiros LJ. Cytogenetic findings in blastoid mantle cell lymphoma. Hum Pathol. 2003 Oct; 34(10):1022-9.

View in: PubMed
Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001 Apr; 115(4):571-81.

View in: PubMed

People

Explore

Similar Concepts

Top Journals